Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study

OBJECTIVES: To assess the impact of extra-articular spondyloarthritis (SpA) manifestations (anterior uveitis, psoriasis and inflammatory bowel disease (IBD)), and of comorbidities, on tumour necrosis factor alpha inhibitor (TNFi) drug retention in ankylosing spondylitis (AS). METHODS: We identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindström, Ulf, Olofsson, Tor, Wedrén, Sara, Qirjazo, Ilia, Askling, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203098/
https://www.ncbi.nlm.nih.gov/pubmed/30402269
http://dx.doi.org/10.1136/rmdopen-2018-000762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203098/
https://www.ncbi.nlm.nih.gov/pubmed/30402269
http://dx.doi.org/10.1136/rmdopen-2018-000762

Ejemplares similares